|
🐜
|
The Hsp90 inhibitor IPI-504 overcomes bortezomib resistance in mantle cell lymphoma in vitro and in vivo by down-regulation of the prosurvival ER chaperone BiP/Grp78.
10 auth.
G. Roué,
P. Pérez-Galán,
A. Mozos,
M. López-Guerra,
S. Xargay-Torrent,
L. Rosich,
...
I. Saborit-Villarroya,
E. Normant,
E. Campo,
D. Colomer
|
6 |
2011 |
6
🐜
|
|
🐜
|
Synergistic antitumor activity of lenalidomide with the BET bromodomain inhibitor CPI203 in bortezomib-resistant mantle cell lymphoma
13 auth.
A. Moros,
V. Rodríguez,
I. Saborit-Villarroya,
A. Montraveta,
P. Balsas,
P. Sandy,
A. Martínez,
A. Wiestner,
E. Normant,
E. Campo,
...
P. Pérez-Galán,
D. Colomer,
G. Roué
|
6 |
2014 |
6
🐜
|
|
🐜
|
Vorinostat-Induced Apoptosis in Mantle Cell Lymphoma Is Mediated by Acetylation of Proapoptotic BH3-Only Gene Promoters
7 auth.
S. Xargay-Torrent,
M. López-Guerra,
I. Saborit-Villarroya,
L. Rosich,
E. Campo,
G. Roué,
...
D. Colomer
|
6 |
2011 |
6
🐜
|
|
🦁
|
The Adaptor Protein 3BP2 Binds Human CD244 and Links this Receptor to Vav Signaling, ERK Activation, and NK Cell Killing1
7 auth.
I. Saborit-Villarroya,
J. D. Del Valle,
X. Romero,
E. Esplugues,
P. Lauzurica,
P. Engel,
...
Margarita Martín
|
5 |
2005 |
5
🦁
|
|
🐜
|
The phosphatidylinositol-3-kinase inhibitor NVP-BKM120 overcomes resistance signals derived from microenvironment by regulating the Akt/FoxO3a/Bim axis in chronic lymphocytic leukemia cells
11 auth.
L. Rosich,
I. Saborit-Villarroya,
M. López-Guerra,
S. Xargay-Torrent,
A. Montraveta,
M. Aymerich,
...
N. Villamor,
E. Campo,
P. Pérez-Galán,
G. Roué,
D. Colomer
|
5 |
2013 |
5
🐜
|
|
🦁
|
E2A is a transcriptional regulator of CD38 expression in chronic lymphocytic leukemia
7 auth.
I. Saborit-Villarroya,
T. Vaisitti,
Davide Rossi,
G. D’Arena,
G. Gaidano,
F. Malavasi,
...
S. Deaglio
|
5 |
2011 |
5
🦁
|
|
🐜
|
Sorafenib Inhibits Cell Migration and Stroma-Mediated Bortezomib Resistance by Interfering B-cell Receptor Signaling and Protein Translation in Mantle Cell Lymphoma
10 auth.
S. Xargay-Torrent,
M. López-Guerra,
A. Montraveta,
I. Saborit-Villarroya,
L. Rosich,
A. Navarro,
...
P. Pérez-Galán,
G. Roué,
E. Campo,
D. Colomer
|
4 |
2012 |
4
🐜
|
|
🐜
|
Antitumoral Activity of Lenalidomide in In Vitro and In Vivo Models of Mantle Cell Lymphoma Involves the Destabilization of Cyclin D1/p27KIP1 Complexes
8 auth.
A. Moros,
S. Bustany,
Julie Cahu,
I. Saborit-Villarroya,
Antonio Martínez,
D. Colomer,
...
B. Sola,
G. Roué
|
4 |
2013 |
4
🐜
|
